EXPANDED TABLE OF CONTENTS
VOLUME 7, NUMBER 3 MARCH 2004
|
| TREATMENT HIGHLIGHTS |
| MOTIVES FOR SELF-CUTTING AND OVERDOSING AMONG ADOLESCENTS |
| Among adolescents, differences are found between motives for self-cutting and for overdosing. |
| TRAUMATIC BRAIN INJURY AND DEPRESSION |
| Among patients with traumatic brain injury, the occurrence of major depression in the year following the trauma is found to be associated with several factors. |
| CIGARETTE SMOKING AND PANIC ATTACKS/PANIC DISORDER |
| Among adolescents and young adults, smoking is found to be associated with an increased risk for subsequent panic attacks and panic disorder. |
| GRADED EXERCISE IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME |
| An intervention encouraging graded exercise is found to improve symptoms of chronic fatigue syndrome. |
| END-OF-LIFE CARE BY FAMILY MEMBERS FOR PERSONS WITH DEMENTIA |
| End-of-life care is found to be extremely demanding for family caregivers of persons with dementia; the death of the patient is associated with feelings of relief and a decrease in depressive symptoms in the caregivers. |
| OF NOTE |
| Demographic Influences on Binge Drinking Among College Students |
| ETCETERA |
|
Substance Use Among 8th- 10th- and 12th-Graders in 2003
|
| PSYCHOTROPIC DRUG COMPARISON STUDY |
| IMPACT OF ABRUPT DISCONTINUATION OF LITHIUM ON COURSE OF BIPOLAR DISORDER |
| Abrupt discontinuation of lithium is associated with a high rate of bipolar disorder relapse soon after discontinuation. |
| NEUROBEHAVIORAL STATUS OF SSRI-EXPOSED INFANTS |
| Healthy, full-birth-weight newborns of women who use selective serotonin reuptake inhibitors (SSRIs) during pregnancy are found to exhibit neurobehavioral disruptions. |
| TRACKING THE DATA |
| WOMEN’S HEALTH INITIATIVE ESTROGEN-ALONE STUDY |
| Participants (postmenopausal women) in the Women’s Health Initiative estrogen-alone study have been directed to discontinue using estrogen. |
| FDA NEWS AND REVIEW |
| Product Safety Information: The labeling for Permax (pergolide mesylate) has been changed to include a warning concerning falling asleep during activities of daily living.
Product Safety Information: The labeling for Zyprexa (olanzapine) has been changed to include a warning concerning stroke and other cerebrovascular adverse events in elderly patients with dementia.
|
| ASSESSMENT |
| Speech Anxiety Thoughts Inventory (SATI) |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |
